Evaluation of Progesterone Receptor Antagonist and Maxi-K Channel Agonist as Neuroprotective in Feeney's Weight Drop Model of TBI.
Kumar MP, Rajput R, Ralta A, Quintans-Júnior LJ, C Gutierrez SJ, Barbosa-Filho JM, Shekhawat D, Radotra BD, Gupta SK, Medhi B.
Kumar MP, et al.
Neurol India. 2022 Jul-Aug;70(4):1601-1609. doi: 10.4103/0028-3886.355164.
Neurol India. 2022.
PMID: 36076665
Free article.
OBJECTIVE: We evaluated two agents, aglepristone (progesterone receptor antagonist) and N-salicyloyltryptamine (STP) (activator of Maxi-K channel in GH3 cells), for neuroprotection in Feeney's weight drop model of TBI. ...
OBJECTIVE: We evaluated two agents, aglepristone (progesterone receptor antagonist) and N-salicyloyltryptamine (STP) (activator of Maxi-K …